CSIMarket
 


Scynexis Inc   (SCYX)
Other Ticker:  
 
 

SCYX's Operating Income Growth by Quarter and Year

Scynexis Inc 's Operating Income results by quarter and year




SCYX Operating Income (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - -22.30 -15.33 -14.11
III Quarter September -21.80 -19.44 -11.51 -11.76
II Quarter June -21.74 -17.51 -11.83 -11.20
I Quarter March -19.74 -1.59 -12.48 -11.86
FY   -63.28 -60.84 -51.15 -48.93



SCYX Operating Income third quarter 2022 Y/Y Growth Comment
Scynexis Inc in the third quarter 2022 recorded Operating Loss of $ -21.80 millions.

According to the results reported in the third quarter 2022, Scynexis Inc achieved the best Operating Income growth in Major Pharmaceutical Preparations industry. While Scynexis Inc ' s Operating Income no change of % ranks overall at the positon no. in the third quarter 2022.

Explain Operating Income growth


SCYX Operating Income ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Scynexis Inc 's third quarter 2022 Operating Income $ -21.80 millions SCYX's Income Statement
Scynexis Inc 's third quarter 2021 Operating Income $ -19.44 millions Quarterly SCYX's Income Statement
New: More SCYX's historic Operating Income Growth >>


SCYX Operating Income (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Operating Income third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Operating Income third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Operating Income by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Scynexis Inc 's Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


SCYX's III. Quarter Q/Q Operating Income Comment
Current results of -21.80 millions by Scynexis Inc appear even more unfavourable if you take a look at Operating Loss -21.74 millions in the second quarter.

Within Major Pharmaceutical Preparations industry Scynexis Inc achieved highest sequential Operating Income growth. While Scynexis Inc 's Operating Income growth quarter on quarter, overall rank is .


Operating Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


SCYX's III. Quarter Q/Q Operating Income Comment
Current accomplishment of -21.80 millions by Scynexis Inc look even worse compare to the Operating Loss -21.74 millions in the previous quarter.

Within Major Pharmaceutical Preparations industry Scynexis Inc achieved highest sequential Operating Income growth. While Scynexis Inc 's Operating Income growth quarter on quarter, overall rank is .


Scynexis Inc 's 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
Cumulative Operating Income 12 Months Ending $ -85.57 $ -83.21 $ -78.98 $ -60.84 $ -53.88
Y / Y Operating Income Growth (TTM) - - - - -
Year on Year Operating Income Growth Overall Ranking # # # # #
Seqeuential Operating Income Change (TTM) - - - - -
Seq. Operating Income Growth (TTM) Overall Ranking # # # # #




Cumulative Operating Income growth Comment
Scynexis Inc ' has realized cumulative trailing twelve months Operating Loss of $ -86 millions in the Sep 30 2022 period.
The results are getting worse as the cumulative Operating Loss is inflating from $ -83.21 millions in the twelve months ending a quarter before and $ -21.74 millions for the twelve months ending in the quarter Sep 30 2021.

Scynexis Inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Operating Income growth Comment
Scynexis Inc ' has realized cumulative trailing twelve months Operating Loss of $ -86 millions in the Sep 30 2022 period.
The business is detiriorating as the cumulative Operating Loss is becoming larger from $ -83.21 millions in TTM ending quarter Jun 30 2022 and $ -21.74 millions from the TTM period ending Sep 30 2021 Leon Claes told.

Scynexis Inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Operating Income Growth
Major Pharmaceutical Preparations Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
SCYX's Operating Income Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for SCYX's Competitors
Operating Income Growth for Scynexis Inc 's Suppliers
Operating Income Growth for SCYX's Customers

You may also want to know
SCYX's Annual Growth Rates SCYX's Profitability Ratios SCYX's Asset Turnover Ratio SCYX's Dividend Growth
SCYX's Roe SCYX's Valuation Ratios SCYX's Financial Strength Ratios SCYX's Dividend Payout Ratio
SCYX's Roa SCYX's Inventory Turnover Ratio SCYX's Growth Rates SCYX's Dividend Comparisons



Companies with similar Operating Income no change for the quarter ending Sep 30 2022 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Sep 30 2022
Bristol myers Squibb Company18.36%$ 18.364 millions
Merit Medical Systems Inc17.11%$ 17.111 millions
Repligen Corp16.53%$ 16.531 millions
Surgery Partners Inc 16.51%$ 16.509 millions
Avantor Inc 16.27%$ 16.273 millions
Bruker Corporation15.99%$ 15.989 millions
Integra Lifesciences Holdings Corp15.26%$ 15.255 millions
Option Care Health Inc 14.82%$ 14.816 millions
Zimmer Biomet Holdings Inc 14.15%$ 14.146 millions
Acadia Healthcare Company Inc 13.82%$ 13.821 millions
Sonida Senior Living Inc 13.67%$ 13.667 millions
Ensign Group Inc12.02%$ 12.016 millions
Globus Medical Inc 11.95%$ 11.950 millions
Mettler Toledo International Inc10.44%$ 10.436 millions
Halozyme Therapeutics Inc 10.20%$ 10.195 millions
Assertio Holdings inc 8.43%$ 8.426 millions
Prestige Consumer Healthcare Inc 7.42%$ 7.416 millions
Organon and Co 6.92%$ 6.925 millions
Abbvie Inc 6.90%$ 6.897 millions
Vertex Pharmaceuticals Inc6.85%$ 6.846 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

IONI's Profile

Stock Price

IONI's Financials

Business Description

Fundamentals

Charts & Quotes

IONI's News

Suppliers

IONI's Competitors

Customers & Markets

Economic Indicators

IONI's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071